Galapagos NV acquired CellPoint B.V. from ND Capital and others for approximately 230 million.
Galapagos NV (ENXTAM:GLPG) entered into agreement to acquire CellPoint B.V. from ND Capital and others for approximately 230 million on June 21, 2022. All-cash transaction includes payment of an upfront amount of 125 million for CellPoint, including consideration for other liabilities associated with the transaction amounting to 10.3 million. Additional contingent consideration up to 100.0 million is due when certain development (20.0 million), regulatory (30.0 million) and sales-based (50.0 million) milestones would be achieved. In a related transaction, Galapagos NV also acquired AboundBio, Inc. for $14 million (13.1 million) in an all-cash transaction on June 21, 2022. Wilson Sonsini Goodrich & Rosati, P.C. acted as legal advisor to CellPoint. Rebecca Kuijpers-Zimmerman, Roel Meers, Oren Livne, and Els Janssens of Baker McKenzie acted as legal advisor to Galapagos NV.
Galapagos NV (ENXTAM:GLPG) completed the acquisition of CellPoint B.V. from ND Capital and others on June 21, 2022